This HTML5 document contains 169 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1177/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q48687986
rdf:type
wikibase:Item
schema:description
artículu científicu vitenskapelig artikkel научная статья artigo científico 2011年學術文章 tieteellinen artikkeli 2011년 논문 научни чланак bài báo khoa học vitskapeleg artikkel tudományos cikk artikull shkencor 2011年学术文章 artigo científico wetenschappelijk artikel 2011年学术文章 ১৮ এপ্রিল ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ teaduslik artikkel мақолаи илмӣ articolo scientifico 2011年學術文章 artículo científico publicado en 2011 scientific article published on 18 April 2011 scientific article published on 18 April 2011 2011年学术文章 บทความทางวิทยาศาสตร์ article científic article scientifique научна статия наукова стаття, опублікована у квітні 2011 article scientific artykuł naukowy 2011年學術文章 artikel ilmiah научни чланак vedecký článok articol științific 2011年の論文 επιστημονικό άρθρο vetenskaplig artikel videnskabelig artikel artigo científico مقالة علمية نشرت في 18 أبريل 2011 bilimsel makale מאמר מדעי vědecký článek scienca artikolo artikulong pang-agham 2011年学术文章 2011 nî lūn-bûn naučni članak wissenschaftlicher Artikel სამეცნიერო სტატია 2011年学术文章 2011年學術文章 scientific article published on 18 April 2011 2011年學術文章 2011年学术文章
p:P577
wds:Q48687986-891933BF-12E7-4FD0-83D1-BAEF9EEF7C07
wdt:P577
2011-04-18T00:00:00Z
p:P2860
wds:Q48687986-0E5A65BB-AC61-4220-AE2C-3A91A3600C20 wds:Q48687986-0F0D0311-1DD5-4E94-8EE6-B69F9240AB90 wds:Q48687986-13D1C795-E2C8-4E9A-A146-643D4BB53405 wds:Q48687986-0049A8D4-7E4A-4A18-8F43-0F37F642CB5D wds:Q48687986-2E474196-E7E6-4F57-8972-6CD523191D69 wds:Q48687986-2EE26B36-7E4D-4108-8EFD-79EB8816B1CF wds:Q48687986-1417A188-5A47-48FD-950F-A5D85BD704AA wds:Q48687986-1D6E705D-2EA1-4E7C-AD86-B98A29E14AFA wds:Q48687986-24F72B3D-56B7-44E0-8860-9AA8E4CDB6AD wds:Q48687986-256077C2-7226-4E50-8679-C8D55522B757 wds:Q48687986-584AF5BB-983B-41A5-8895-FF3FB3240ABD wds:Q48687986-58BB46E9-CE5C-417C-AA03-1FFCDD5086E1 wds:Q48687986-69B23A26-1A64-41A7-B54B-BEB450095F24 wds:Q48687986-3C1A5F90-AB7F-425F-B902-BB27803D0894 wds:Q48687986-42A80804-5D63-4287-8D2D-618CF0A43CD1 wds:Q48687986-8B1AE239-E7CF-4E9E-94BF-1792E1285754 wds:Q48687986-82D9EA2F-FCDF-4D96-B2A8-DB5831528DF8 wds:Q48687986-9964B98B-D4B5-4CE6-B959-1D1A21FE34B5 wds:Q48687986-8B6FC41A-9B50-44A9-86D6-2E3C68BD4D16 wds:Q48687986-8D9A3216-0F8C-4800-8019-43A185084882 wds:Q48687986-D45F5628-BE34-4E90-AA77-9782A20787F4 wds:Q48687986-D756F5B5-AED4-4DAB-8AE3-1CF10EBAA5DE wds:Q48687986-F4050F8A-6EB1-4359-B0A5-5D76E8301234 wds:Q48687986-DAA707DD-43C2-4EDE-B8BD-856F8BAF168B wds:Q48687986-EC2A305A-D42C-4C99-BE2C-94B617783122
wdt:P2860
wd:Q35250764 wd:Q53185335 wd:Q48591043 wd:Q53260720 wd:Q50909003 wd:Q29616244 wd:Q48293543 wd:Q53101555 wd:Q34002802 wd:Q37258747 wd:Q31038381 wd:Q51931832 wd:Q53670137 wd:Q28296987 wd:Q50759143 wd:Q34662511 wd:Q44630260 wd:Q37387951 wd:Q51015158 wd:Q51952494 wd:Q36244727 wd:Q48445074 wd:Q48952313 wd:Q48945801 wd:Q42622627
p:P2093
wds:Q48687986-64E9C1A0-818A-426C-B543-3EDFBC491BA6 wds:Q48687986-6F09A5E3-6ACC-4778-901F-ABF04BD5A940 wds:Q48687986-3373D093-71A5-4E4D-86E8-F4B9D7ECC546 wds:Q48687986-DFAE91EB-F3E2-4221-9D77-3B9FF22AFC2B wds:Q48687986-FF37B4C9-63F3-412B-9DB4-A8E66BAEC729 wds:Q48687986-CB055E6F-231D-4F0F-A8FD-5879E85C9556 wds:Q48687986-D1C3B0A5-1DD6-423F-A8E7-56174ED0FD90
wdt:P2093
S Cottone COGIMUS Study Group F Patti C Gasperini M P Amato M R Tola S Cilia
rdfs:label
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
skos:prefLabel
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
schema:name
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
p:P50
wds:Q48687986-6AAE21A7-5FE7-4565-9DE7-F1ED365F2912 wds:Q48687986-5769E21B-0DBE-493D-95ED-09D727BEF2B1 wds:Q48687986-C38D38F7-B3E7-459E-994C-6E6571A0D0E0 wds:Q48687986-8F1476CB-7033-4400-92DB-76531CDF9B86 wds:Q48687986-9BC85BBC-E834-4A6C-B6C5-0AC6AF0CFFFD
wdt:P50
wd:Q38546631 wd:Q41721876 wd:Q42327537 wd:Q42218235 wd:Q47504554
p:P1476
wds:Q48687986-3B872DC2-E39D-48E1-8022-74B21F623FA4
wdt:P1476
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
p:P304
wds:Q48687986-3C1366D7-4B11-4D6D-B49B-F15D0E67EBEC
wdt:P304
991-1001
p:P31
wds:Q48687986-AD3F1F14-E416-4BBB-994F-F3442B7073D3
wdt:P31
wd:Q13442814
p:P921
wds:Q48687986-91E01637-F5BE-4AA1-B2EF-73B0A9F38977 wds:Q48687986-985DFE03-4BDD-407E-994A-86FECB459F26 wds:Q48687986-A127FF3B-1321-43CA-8091-01E828B8A2FC wds:Q48687986-E876FEE9-D5EE-407C-9FEC-ED2AE4B62B76
wdt:P921
wd:Q8277 wd:Q13100823 wd:Q57859955 wd:Q18555066
p:P698
wds:Q48687986-873B38FD-80D9-42D5-9CF5-62F380DFDDB6
wdtn:P698
n11:21502310
wdt:P698
21502310
p:P1433
wds:Q48687986-7E7F6680-AC56-4716-ABF1-4ADC9F25EB73
wdt:P1433
wd:Q1952449
p:P433
wds:Q48687986-07FD8EBB-CBE9-4236-9A56-AAF47ECE686A
p:P478
wds:Q48687986-CE434EDE-61EB-4CC1-B116-5746FDE7C15A
wdt:P433
8
wdt:P478
17
p:P356
wds:Q48687986-86CC0AB0-5B59-4671-805D-B60E700DF074
wdtn:P356
n12:1352458511401943
wdt:P356
10.1177/1352458511401943
p:P5875
wds:Q48687986-B1E71AAB-124A-4B14-9F91-6B9C9A0C5DE9
wdt:P5875
51060071